Internal mammary sentinel lymph node biopsy in breast cancer: accurate staging and individualized treatment

The aim of this study was to determine the impact of routinely performed internal mammary sentinel lymph node biopsy (IM-SLNB) on the staging and treatment, and to analyze the success rate, complications and learning curve. All patients with biopsy-proven breast cancer who underwent sentinel lymph n...

Full description

Saved in:
Bibliographic Details
Published inZhōnghuá zhŏngliú zázhì Vol. 38; no. 1; pp. 42 - 47
Main Authors Qiu, Pengfe, Zhao, Rongrong, Cong, Binbin, Yang, Guoren, Liu, Yanbing, Chen, Peng, Sun, Xiao, Wang, Chunjian, Wang, Yongsheng
Format Journal Article
LanguageChinese
Published China 01.01.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aim of this study was to determine the impact of routinely performed internal mammary sentinel lymph node biopsy (IM-SLNB) on the staging and treatment, and to analyze the success rate, complications and learning curve. All patients with biopsy-proven breast cancer who underwent sentinel lymph node biopsy between 2012 and 2014 were included in a prospective analysis. Internal mammary sentinel lymph node biopsy (IM-SLNB) was performed in all patients with IM-SLN visualized on preoperative lymphoscintigraphy and/or detected by intraoperative gamma probe detection. The adjuvant treatment plan was adjusted according to the current guidelines. In a total of 349 patients, 249 patients (71.1%) showed internal mammary drainage. IM-SLNB was performed in 153 patients with internal mammary drainage, with a success rate of IM-SLNB of 97.4% (149/153). Pleural lesion and internal mammary artery bleeding were found in 7.2% and 5.2% patients, respectively. In 8.1% of patients (12/149) the IM-SLN was tumor positive. In th
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0253-3766
DOI:10.3760/cma.j.issn.0253-3766.2016.01.009